Levy, J. H., Ghadimi, K., Faraoni, D., van Diepen, S., Levy, B., Hotchkiss, R., … Warkentin, T. E. (2019). Ischemic limb necrosis in septic shock: What is the role of high-dose vasopressor therapy? J Thromb Haemost, 17(11), 1973–1978. https://doi.org/10.1111/jth.14566

Levy, Jerrold H., Kamrouz Ghadimi, David Faraoni, Sean van Diepen, Bruno Levy, Richard Hotchkiss, Jean M. Connors, Toshiaki Iba, and Theodore E. Warkentin. “Ischemic limb necrosis in septic shock: What is the role of high-dose vasopressor therapy?” J Thromb Haemost 17, no. 11 (November 2019): 1973–78. https://doi.org/10.1111/jth.14566.

Levy JH, Ghadimi K, Faraoni D, van Diepen S, Levy B, Hotchkiss R, et al. Ischemic limb necrosis in septic shock: What is the role of high-dose vasopressor therapy? J Thromb Haemost. 2019 Nov;17(11):1973–8.

Levy, Jerrold H., et al. “Ischemic limb necrosis in septic shock: What is the role of high-dose vasopressor therapy?” J Thromb Haemost, vol. 17, no. 11, Nov. 2019, pp. 1973–78. Pubmed, doi:10.1111/jth.14566.

Levy JH, Ghadimi K, Faraoni D, van Diepen S, Levy B, Hotchkiss R, Connors JM, Iba T, Warkentin TE. Ischemic limb necrosis in septic shock: What is the role of high-dose vasopressor therapy? J Thromb Haemost. 2019 Nov;17(11):1973–1978.